Aquestive Therapeutics Inc (AQST) — Cash Flow Reinvestment Rate
Aquestive Therapeutics Inc (AQST) has a Cash Flow Reinvestment Rate of 0.00x as of March 2023, reinvesting $4.00K (capex $2.00K plus investments $-2.00K) from operating cash flow of $8.82 Million. Explore Aquestive Therapeutics Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Aquestive Therapeutics Inc Cash Flow Reinvestment Rate (2017–2017)
Historical reinvestment intensity for Aquestive Therapeutics Inc across 1 annual periods. Also explore total assets of Aquestive Therapeutics Inc for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Aquestive Therapeutics Inc (2017–2017)
Year-by-year capital reinvestment analysis for Aquestive Therapeutics Inc. For live market cap and broader valuation context, see market cap of Aquestive Therapeutics Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2017 | 0.71x | $4.14 Million | $5.82 Million | $2.07 Million | — |